In last trading session, SELLAS Life Sciences Group Inc (NASDAQ:SLS) saw 0.74 million shares changing hands with its beta currently measuring 2.42. Company’s recent per share price level of $1.23 trading at $0.07 or 6.03% at ring of the bell on the day assigns it a market valuation of $79.13M. That closing price of SLS’s stock is at a discount of -39.84% from its 52-week high price of $1.72 and is indicating a premium of 59.35% from its 52-week low price of $0.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.57 million shares which gives us an average trading volume of 521.57K if we extend that period to 3-months.

For SELLAS Life Sciences Group Inc (SLS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.13 in the current quarter.

SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information

Upright in the green during last session for gaining 6.03%, in the last five days SLS remained trading in the green while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $1.23 price level, adding 0.81% to its value on the day. SELLAS Life Sciences Group Inc’s shares saw a change of 16.04% in year-to-date performance and have moved 3.36% in past 5-day. SELLAS Life Sciences Group Inc (NASDAQ:SLS) showed a performance of 2.50% in past 30-days. Number of shares sold short was 6.08 million shares which calculate 12.41 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 7 to the stock, which implies a rise of 82.43% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 8. It follows that stock’s current price would drop -387.8% in reaching the projected high whereas dropping to the targeted low would mean a loss of -387.8% for stock’s current value.

SELLAS Life Sciences Group Inc (SLS) estimates and forecasts

Statistics highlight that SELLAS Life Sciences Group Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -9.23% of value to its shares in past 6 months, showing an annual growth rate of 58.96% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 61.44% during past 5 years.

SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s Major holders

Insiders are in possession of 0.24% of company’s total shares while institution are holding 9.57 percent of that, with stock having share float percentage of 9.59%. Investors also watch the number of corporate investors in a company very closely, which is 9.57% institutions for SELLAS Life Sciences Group Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at SLS for having 1.79 million shares of worth $2.13 million. And as of 2024-06-30, it was holding 3.9862 of the company’s outstanding shares.

The second largest institutional holder is SUSQUEHANNA INTERNATIONAL GROUP, LLP, which was holding about 1.64 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.6594 of outstanding shares, having a total worth of $1.95 million.